What are the responsibilities and job description for the Scientist I (Translational Therapeutics; Traumatic Brain Injury) - Bethesda, MD position at National Neurotrauma Society?
Scientist I (Translational Therapeutics; Traumatic Brain Injury) - Bethesda, MD
Position title : Scientist I (Translational Therapeutics; Traumatic Brain Injury)
Ensure you read the information regarding this opportunity thoroughly before making an application.
Organization : USUHS and Henry M. Jackson Foundation for the Advancement of Military Medicine
Location : Bethesda, MD
Position ID : 2024-4093
This Scientist I position will support the Translational Therapeutics Core of the Military Traumatic Brain Injury Initiative (MTBI 2) in the School of Medicine at the Uniformed Services University of the Health Sciences in Bethesda, Maryland. This investigator will be responsible for initiating and carrying out research projects in collaboration with a research team, under the direction of Dr. Regina Armstrong, Chair of the Department of Anatomy, Physiology and Genetics within the School of Medicine. The person selected for this position will conduct research in experimental models to screen therapies to promote regeneration and plasticity to protect against neurodegeneration and chronic symptoms associated with traumatic brain injury (TBI) and related clinical conditions.
This position will be located in the School of Medicine in the Translational Therapeutics Core of the Military Traumatic Brain Injury Initiative (MTBI 2) at the Uniformed Services University of the Health Sciences. The research team values a collaborative environment that supports diverse team members conducting multi-disciplinary research. We are examining therapeutic targets for traumatic brain injury (TBI) and evaluating candidate therapeutics for repurposing to TBI as a new clinical indication. Strong applicants will be able to bring expertise in molecular profiling and pathway analyses and / or electrophysiology to complement our ongoing transcriptomic, neuropathological, biochemical, behavioral, and neuroimaging approaches for research in acute stage therapeutics in experimental models of TBI.
J-18808-Ljbffr
